[en] BACKGROUND AND OBJECTIVE: To evaluate the analgesic efficacy and safety of gabapentin in the treatment of carpal tunnel syndrome (CTS), as well as the electromyographic (EMG) evolution after 6 months. PATIENTS AND METHOD: A prospective study with a 6-month follow-up of patients with EMG diagnosis of primary CTS starting treatment with 1.800 mg/day of gabapentin. At baseline visit and after 6 months of treatment a complete clinical evaluation and an EMG study were performed. Adverse effects of gabapentin were also registered. RESULTS: Twenty-five patients were included, mean age (standard deviation) 58.88 (7.69) years. After 6 months of treatment, a statistically significant reduction of pain (p = 0.001) and improvement of severity of symptoms (p = 0.008) were observed, although functional capacity did not change. EMG was performed in 19 patients at 6 months. Compared to baseline EMG: 52.6% patients showed no changes in EMG findings, while 5.3% patients showed improvement and in 26.3% the EMG was normal. Progression was only seen in 15.8% of patients after 6 months of treatment. In 28% of the patients gabapentin was stopped because of side effects. CONCLUSIONS: In our series, gabapentin was effective in the reduction of pain and improvement of the severity of the symptoms. Results of EMG after 6 months of treatment showed no changes, with improvement and/or remission in 84.2% of the cases. The drug was safe and well tolerated.
D.W. Levine B.P. Simmons M.J. Koris L.H. Daltroy G.G. Hohl A.H. Fossel A self-administered questionnaire for the assessment of severity of symptoms and functional status in carpal tunnel syndrome J Bone Joint Surg Am 75 1993 1585 1592
D. De la Torre González J.A. Pérez Meave J. Góngora López V.M. Hurta Olivares Evaluación de pacientes con traumatismo raquimedular clínico y radiológico Trauma 4 2001 22 28
A.A.M. Gerritsen H.C.W. De Vet R.J.P.M. Scholten F.W. Bertelsmann M.C.T.F.M. De Krom L.M. Bouter Splinting vs surgery in the treatment of carpal tunnel syndrome: a randomized controlled trial JAMA 288 2002 1245 1251
D. O’Connor S. Marshall N. Massy-Westropp Non-surgical treatment (other than steroid injection) for carpal tunnel syndrome Cochrane Database Syst Rev 1 2003 CD003219
S.J. Kaplan S.Z. Glickel R.J. Eaton Predictive factors in the non-surgical treatment of carpal tunnel syndrome J Hand Surg Am 15 1990 106 108
W. Richard M.D. Rosenquist Advances in therapeutics and diagnostics. Gabapentin J Am Acad Orthop Surg 10 2002 153 156
F.M. Canadillas-Hidalgo The safety and tolerability profile of gabapentin in optimal doses Rev Neurol 39 2004 371 380
A. Formica K. Verger J.M. Sol C. Morralla Efectividad de la gabapentina en el tratamiento de la espasticidad: estudio aleatorizado, a doble ciego y controlado con placebo Med Clin (Barc) 124 2005 81 85
M. Serrao P. Rossi P. Cardinali G. Valente L. Parisi F. Pierelli Gabapentin treatment for muscle cramps: an open-label trial Clin Neuropharmacol 23 2000 45 49